Novel multivalent S100A8 inhibitory peptides attenuate tumor progression and metastasis by inhibiting the TLR4-dependent pathwayAtsuko Deguchi, Yoshiro Maru|Cancer Gene Therapy|2023Cited by 12
Paradoxical counteraction by imatinib against cell death in myeloid progenitor 32D cells expressing p210BCR-ABLMorichika Takita, Yoshiro Maru|Oncotarget|2018Cited by 4
Novel multivalent S100A8 inhibitory peptides attenuate tumor progression and metastasis by inhibiting the TLR4-dependent pathwayAtsuko Deguchi, Yoshiro Maru|Research Square|2022Cited by 1